{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:20:24Z","timestamp":1752668424071,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Atrial fibrillation is a cardiac arrhythmia commonly encountered in a primary care setting. Current screening is limited to pulse palpation and ECG confirmation when an irregular pulse is found. Paroxysmal atrial fibrillation will, however, still be difficult to pick up. With the advent of smartphones, screening could be more cost-efficient by making use of simple applications, lowering the need for intensive screening to discover (paroxysmal) atrial fibrillation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods\/design<\/jats:title>\n                <jats:p>This cluster randomized trial will examine the effect of using a smartphone-based application such as FibriCheck\u00ae on the detection rate of atrial fibrillation in a Flemish general practice population. This study will be conducted in 22 primary care practices across the Flanders region of Belgium and will last 12\u2009months. Patients above 65\u2009years of age will be divided in control and intervention groups on the practice level. The control group will be subjected to standard opportunistic screening only, while the intervention group will be prescribed the FibriCheck\u00ae app on top of this opportunistic screening. The difference in detection rate between control and intervention groups will be calculated at the end of the study.<\/jats:p>\n                <jats:p>We will use the online platform INTEGO for pseudonymized data collection and analysis, and risk calculation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Smartphone applications might offer a way to cost-effectively screen for (paroxysmal) atrial fibrillation in a primary care setting. This could open the door for the update of future screening guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04545723\">NCT04545723<\/jats:ext-link>. Registered on September 10, 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05497-x","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T08:03:24Z","timestamp":1628496204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effect of a case-finding app on the detection rate of atrial fibrillation compared with opportunistic screening in primary care patients: protocol for a cluster randomized trial"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3695-2452","authenticated-orcid":false,"given":"Simon Gabri\u00ebl","family":"Beerten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine","family":"Proesmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Vaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"issue":"1","key":"5497_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1472-6947-14-48","volume":"14","author":"C Truyers","year":"2014","unstructured":"Truyers C, Goderis G, Dewitte H, vanden AM, Buntinx F. The Intego database: background, methods and basic results of a Flemish general practice-based continuous morbidity registration project. BMC Med Inform Decis Mak. 2014;14(1):48.","journal-title":"BMC Med Inform Decis Mak"},{"key":"5497_CR2","unstructured":"Department of Public Health and Primary Care, KU Leuven. INTEGO Project. 2011. [online], [https:\/\/intego.be]."},{"issue":"11","key":"5497_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","volume":"11","author":"F Rahman","year":"2014","unstructured":"Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014;11(11):639\u201354. https:\/\/doi.org\/10.1038\/nrcardio.2014.118.","journal-title":"Nat Rev Cardiol."},{"issue":"3","key":"5497_CR4","doi-asserted-by":"publisher","first-page":"e13070","DOI":"10.1111\/ijcp.13070","volume":"72","author":"H Zulkifly","year":"2018","unstructured":"Zulkifly H, Lip GYH, Lane DA. Epidemiology of atrial fibrillation. Int J Clin Pract. 2018;72(3):e13070. https:\/\/doi.org\/10.1111\/ijcp.13070.","journal-title":"Int J Clin Pract."},{"issue":"5","key":"5497_CR5","doi-asserted-by":"publisher","first-page":"e005155","DOI":"10.1161\/JAHA.116.005155","volume":"6","author":"DA Lane","year":"2017","unstructured":"Lane DA, Skj\u00f8th F, Lip GYH, Larsen TB, Kotecha D. Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care. J Am Heart Assoc. 2017;6(5):e005155.","journal-title":"J Am Heart Assoc."},{"key":"5497_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/CLEP.S47385","volume":"6","author":"M Zoni-Berisso","year":"2014","unstructured":"Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213\u201320. https:\/\/doi.org\/10.2147\/CLEP.S47385.","journal-title":"Clin Epidemiol."},{"issue":"8","key":"5497_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983\u20138. https:\/\/doi.org\/10.1161\/01.STR.22.8.983.","journal-title":"Stroke."},{"issue":"9","key":"5497_CR8","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1161\/STROKEAHA.114.006070","volume":"45","author":"L Friberg","year":"2014","unstructured":"Friberg L, Rosenqvist M, Lindgren A, Ter\u00e9nt A, Norrving B, Asplund K. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke. 2014;45(9):2599\u2013605. https:\/\/doi.org\/10.1161\/STROKEAHA.114.006070.","journal-title":"Stroke."},{"issue":"1","key":"5497_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1186\/s12913-017-2652-y","volume":"17","author":"SP Johnsen","year":"2017","unstructured":"Johnsen SP, Dalby LW, T\u00e4ckstr\u00f6m T, Olsen J, Fraschke A. Cost of illness of atrial fibrillation: a nationwide study of societal impact. BMC Health Serv Res. 2017;17(1):714. https:\/\/doi.org\/10.1186\/s12913-017-2652-y.","journal-title":"BMC Health Serv Res."},{"issue":"8","key":"5497_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jval.2017.04.018","volume":"20","author":"JV Santos","year":"2017","unstructured":"Santos JV, Pereira J, Pinto R, Castro PM, Azevedo E, Freitas A. Atrial Fibrillation as an Ischemic Stroke Clinical and Economic Burden Modifier: A 15-Year Nationwide Study. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2017 Sep;20(8):1083\u201391. https:\/\/doi.org\/10.1016\/j.jval.2017.04.018.","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res."},{"issue":"3","key":"5497_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000330348","volume":"32","author":"T Rizos","year":"2011","unstructured":"Rizos T, Wagner A, Jenetzky E, Ringleb PA, Becker R, Hacke W, et al. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis Basel Switz. 2011;32(3):276\u201382. https:\/\/doi.org\/10.1159\/000330348.","journal-title":"Cerebrovasc Dis Basel Switz."},{"issue":"7\u20138","key":"5497_CR12","first-page":"535","volume":"36","author":"J Primo","year":"2017","unstructured":"Primo J, Gon\u00e7alves H, Macedo A, Russo P, Monteiro T, Guimar\u00e3es J, et al. Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring. Rev Port Cardiol Orgao Of Soc Port Cardiol Port J Cardiol Off J Port Soc Cardiol. 2017;36(7\u20138):535\u201346.","journal-title":"Rev Port Cardiol Orgao Of Soc Port Cardiol Port J Cardiol Off J Port Soc Cardiol."},{"issue":"4","key":"5497_CR13","doi-asserted-by":"publisher","first-page":"e0195088","DOI":"10.1371\/journal.pone.0195088","volume":"13","author":"MP Turakhia","year":"2018","unstructured":"Turakhia MP, Shafrin J, Bognar K, Trocio J, Abdulsattar Y, Wiederkehr D, et al. Estimated prevalence of undiagnosed atrial fibrillation in the United States. PloS One. 2018;13(4):e0195088. https:\/\/doi.org\/10.1371\/journal.pone.0195088.","journal-title":"PloS One."},{"issue":"2","key":"5497_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372. https:\/\/doi.org\/10.1378\/chest.09-1584.","journal-title":"Chest."},{"issue":"2","key":"5497_CR15","doi-asserted-by":"publisher","first-page":"e000102","DOI":"10.1161\/JAHA.112.000102","volume":"2","author":"A Alonso","year":"2013","unstructured":"Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2(2):e000102. https:\/\/doi.org\/10.1161\/JAHA.112.000102.","journal-title":"J Am Heart Assoc."},{"key":"5497_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ahj.2016.05.004","volume":"178","author":"IE Christophersen","year":"2016","unstructured":"Christophersen IE, Yin X, Larson MG, Lubitz SA, Magnani JW, McManus DD, et al. A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study. Am Heart J. 2016;178:45\u201354. https:\/\/doi.org\/10.1016\/j.ahj.2016.05.004.","journal-title":"Am Heart J."},{"issue":"40","key":"5497_CR17","first-page":"iii\u2013iv, ix\u2013x, 1","volume":"9","author":"FDR Hobbs","year":"2005","unstructured":"Hobbs FDR, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess Winch Engl. 2005;9(40):iii\u2013iv, ix\u2013x, 1\u201374.","journal-title":"Health Technol Assess Winch Engl"},{"issue":"7616","key":"5497_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/bmj.39280.660567.55","volume":"335","author":"DA Fitzmaurice","year":"2007","unstructured":"Fitzmaurice DA, Hobbs FDR, Jowett S, Mant J, Murray ET, Holder R, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ. 2007;335(7616):383. https:\/\/doi.org\/10.1136\/bmj.39280.660567.55.","journal-title":"BMJ."},{"key":"5497_CR19","first-page":"CD009586","volume":"6","author":"PS Moran","year":"2016","unstructured":"Moran PS, Teljeur C, Ryan M, Smith SM. Systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev. 2016;6:CD009586.","journal-title":"Cochrane Database Syst Rev."},{"issue":"7","key":"5497_CR20","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.amjcard.2014.07.016","volume":"114","author":"J Wiesel","year":"2014","unstructured":"Wiesel J, Arbesfeld B, Schechter D. Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol. 2014;114(7):1046\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2014.07.016.","journal-title":"Am J Cardiol."},{"issue":"9","key":"5497_CR21","first-page":"1291","volume":"16","author":"RG Tieleman","year":"2014","unstructured":"Tieleman RG, Plantinga Y, Rinkes D, Bartels GL, Posma JL, Cator R, et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2014;16(9):1291\u20135.","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol."},{"issue":"1","key":"5497_CR22","first-page":"24","volume":"103","author":"N-Y Chan","year":"2017","unstructured":"Chan N-Y, Choy C-C. Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram. Heart Br Card Soc. 2017;103(1):24\u201331.","journal-title":"Heart Br Card Soc."},{"issue":"3","key":"5497_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/pace.12053","volume":"36","author":"MA Rosenberg","year":"2013","unstructured":"Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol PACE. 2013;36(3):328\u201333. https:\/\/doi.org\/10.1111\/pace.12053.","journal-title":"Pacing Clin Electrophysiol PACE."},{"issue":"1","key":"5497_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/13814788.2017.1374366","volume":"23","author":"MR Fay","year":"2017","unstructured":"Fay MR, Fitzmaurice DA, Freedman B. Screening of older patients for atrial fibrillation in general practice: Current evidence and its implications for future practice. Eur J Gen Pract. 2017;23(1):246\u201353. https:\/\/doi.org\/10.1080\/13814788.2017.1374366.","journal-title":"Eur J Gen Pract."},{"issue":"11","key":"5497_CR25","doi-asserted-by":"publisher","first-page":"N79","DOI":"10.1088\/0967-3334\/31\/11\/N01","volume":"31","author":"E Jonathan","year":"2010","unstructured":"Jonathan E, Leahy M. Investigating a smartphone imaging unit for photoplethysmography. Physiol Meas. 2010;31(11):N79\u201383. https:\/\/doi.org\/10.1088\/0967-3334\/31\/11\/N01.","journal-title":"Physiol Meas."},{"issue":"3","key":"5497_CR26","doi-asserted-by":"publisher","first-page":"e12284","DOI":"10.2196\/12284","volume":"7","author":"T Proesmans","year":"2019","unstructured":"Proesmans T, Mortelmans C, Van Haelst R, Verbrugge F, Vandervoort P, Vaes B. Mobile Phone-Based Use of the Photoplethysmography Technique to Detect Atrial Fibrillation in Primary Care: Diagnostic Accuracy Study of the FibriCheck App. JMIR MHealth UHealth. 2019;7(3):e12284. https:\/\/doi.org\/10.2196\/12284.","journal-title":"JMIR MHealth UHealth."},{"issue":"4","key":"5497_CR27","doi-asserted-by":"publisher","first-page":"e24461","DOI":"10.2196\/24461","volume":"5","author":"SG Beerten","year":"2021","unstructured":"Beerten SG, Proesmans T, Vaes B. A Heart Rate Monitoring App (FibriCheck) for Atrial Fibrillation in General Practice: Pilot Usability Study. JMIR Form Res. 2021;5(4):e24461. https:\/\/doi.org\/10.2196\/24461.","journal-title":"JMIR Form Res."},{"issue":"4","key":"5497_CR28","doi-asserted-by":"publisher","first-page":"e11428","DOI":"10.2196\/11428","volume":"6","author":"N Delvaux","year":"2018","unstructured":"Delvaux N, Aertgeerts B, van Bussel JC, Goderis G, Vaes B, Vermandere M. Health Data for Research Through a Nationwide Privacy-Proof System in Belgium: Design and Implementation. JMIR Med Inform. 2018;6(4):e11428. https:\/\/doi.org\/10.2196\/11428.","journal-title":"JMIR Med Inform."},{"issue":"5","key":"5497_CR29","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093\u2013100. https:\/\/doi.org\/10.1378\/chest.10-0134.","journal-title":"Chest."},{"issue":"9","key":"5497_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/clc.22435","volume":"38","author":"W Zhu","year":"2015","unstructured":"Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis. Clin Cardiol. 2015;38(9):555\u201361. https:\/\/doi.org\/10.1002\/clc.22435.","journal-title":"Clin Cardiol."},{"issue":"38","key":"5497_CR31","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893\u2013962. https:\/\/doi.org\/10.1093\/eurheartj\/ehw210.","journal-title":"Eur Heart J."},{"issue":"25","key":"5497_CR32","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","volume":"131","author":"E Svennberg","year":"2015","unstructured":"Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study. Circulation. 2015;131(25):2176\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.014343.","journal-title":"Circulation."},{"issue":"19","key":"5497_CR33","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.117.030583","volume":"136","author":"JPJ Halcox","year":"2017","unstructured":"Halcox JPJ, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, et al. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation. 2017;136(19):1784\u201394. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030583.","journal-title":"Circulation."},{"issue":"1","key":"5497_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s13063-015-1006-5","volume":"16","author":"SB Uittenbogaart","year":"2015","unstructured":"Uittenbogaart SB, Verbiest-van Gurp N, Erkens PMG, Lucassen WAM, Knottnerus JA, Winkens B, et al. Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial. Trials. 2015;16(1):478. https:\/\/doi.org\/10.1186\/s13063-015-1006-5.","journal-title":"Trials."},{"key":"5497_CR35","doi-asserted-by":"publisher","first-page":"m3208","DOI":"10.1136\/bmj.m3208","volume":"370","author":"SB Uittenbogaart","year":"2020","unstructured":"Uittenbogaart SB, Gurp NV, Lucassen WAM, Winkens B, Nielen M, Erkens PMG, et al. Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. BMJ. 2020;370:m3208.","journal-title":"BMJ."},{"issue":"1","key":"5497_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2474-7-64","volume":"7","author":"JA Radford","year":"2006","unstructured":"Radford JA, Landorf KB, Buchbinder R, Cook C. Effectiveness of low-Dye taping for the short-term treatment of plantar heel pain: a randomised trial. BMC Musculoskelet Disord. 2006;7(1):64. https:\/\/doi.org\/10.1186\/1471-2474-7-64.","journal-title":"BMC Musculoskelet Disord."},{"issue":"6","key":"5497_CR37","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.5811\/westjem.2017.8.35985","volume":"18","author":"CE McCoy","year":"2017","unstructured":"McCoy CE. Understanding the Intention-to-treat Principle in Randomized Controlled Trials. West J Emerg Med. 2017;18(6):1075\u20138. https:\/\/doi.org\/10.5811\/westjem.2017.8.35985.","journal-title":"West J Emerg Med."},{"issue":"1","key":"5497_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ije\/dyx169","volume":"47","author":"C Leyrat","year":"2018","unstructured":"Leyrat C, Morgan KE, Leurent B, Kahan BC. Cluster randomized trials with a small number of clusters: which analyses should be used? Int J Epidemiol. 2018;47(1):321\u201331. https:\/\/doi.org\/10.1093\/ije\/dyx169.","journal-title":"Int J Epidemiol."},{"issue":"8","key":"5497_CR39","first-page":"1167","volume":"21","author":"FH Verbrugge","year":"2019","unstructured":"Verbrugge FH, Proesmans T, Vijgen J, Mullens W, Rivero-Ayerza M, Van Herendael H, et al. Atrial fibrillation screening with photo-plethysmography through a smartphone camera. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2019;21(8):1167\u201375.","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05497-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T08:23:19Z","timestamp":1628497399000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05497-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5497"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05497-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the Ethics Committee of University Hospitals Leuven, Belgium on May 14, 2020. Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"TP is an employee of Qompium, the company that provides the FibriCheck\u00ae app. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"525"}}